Q4 |
4A-81%, 4B-79.5%, 4C-59.5%, 4D-70.2%, 4E-78% |
Q5 |
5A-85.9%, 5B-68.3%, 5C-66.3%, 5D-35.6%, 5E-43.9% |
Q6 |
6A-86.8%, 6B-76.6%, 6C-56.6%, 6D-64.4%, 6E-15.6% |
Q7 |
7A-62.4%, 7B-55.6%, 7C-57.6%, 7D-69.3%, 7E-55.1% |
Q8 |
48 (23.4%) Negative, 157 (76.6%) Affirmative |
Q9 |
35 (17.1%) Negative, 170 (82.9%) Affirmative |
Q10 |
17 (8.3%) Negative, 188 (91.7%) Affirmative |
Q11 |
11A-78.5%, 11B-75.6%, 11C-54.6%, 11D-78%, 11E-62.9% |
Q12 |
12A-82.9%, 12B-70.2%, 12C-35.6%, 12D-35.6%, 12E-42.9% |
Q13 |
13A-53.2%, 13B-51.7%, 13C-77.1%, 13D-52.7%, 13E-64.9% |
Q14 |
14A-61.5%, 14B-91.7%, 14C-58%, 14D-42.4%, 14E-44.4% |
Q15 |
31 (15.1%) Negative, 174 (84.9%) Affirmative |
Q16 |
20 (9.8%) Negative, 185 (90.2%) Affirmative |
Q17 |
15 (7.3%) Negative, 190 (92.7%) Affirmative |
Q18 |
7 (3.4%) Negative, 198 (96.6%) Affirmative |
Q19 |
15 (7.3%) Negative, 190 (92.7%) Affirmative |
Q20 |
7 (3.4%) Negative, 198 (96.6%) Affirmative |